<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font22 { font-size : 22; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">HIV- </span>
   <span class="font30">HBV </span>
   <span class="font22">(): </span>
   <span class="font21">viral </span>
   <span class="font20">cells </span>
   <span class="font20">cure </span>
   <span class="font17">cell </span>
   <span class="font16">[]. </span>
   <span class="font16">cccDNA </span>
   <span class="font15">infection </span>
   <span class="font15">immune </span>
   <span class="font15">HIV </span>
   <span class="font14">infected </span>
   <span class="font14">ART </span>
   <span class="font14">virus </span>
   <span class="font14">therapeutic </span>
   <span class="font14">gene </span>
   <span class="font13">hepatitis </span>
   <span class="font13">immunity </span>
   <span class="font13">presented </span>
   <span class="font13">approach </span>
   <span class="font13">DNA </span>
   <span class="font13">replication </span>
   <span class="font13">treatment </span>
   <span class="font13">{border-style </span>
   <span class="font13">expression </span>
   <span class="font13">using </span>
   <span class="font13">associated </span>
   <span class="font13">px;} </span>
   <span class="font12">#ffffff;} </span>
   <span class="font12">antigen </span>
   <span class="font12">cells. </span>
   <span class="font12">chronic </span>
   <span class="font12">infection. </span>
   <span class="font12">intact </span>
   <span class="font12">potential </span>
   <span class="font12">proviruses </span>
   <span class="font12">reservoir </span>
   <span class="font12">therapy </span>
   <span class="font12">Med; </span>
   <span class="font12">clinical </span>
   <span class="font12">persistence </span>
   <span class="font12">data </span>
   <span class="font12">include </span>
   <span class="font12">integrated </span>
   <span class="font12">HBsAg </span>
   <span class="font12">antibodies </span>
   <span class="font12">cure. </span>
   <span class="font12">need </span>
   <span class="font12">responses </span>
   <span class="font12">studies </span>
   <span class="font12">use </span>
   <span class="font12">USA) </span>
   <span class="font12">following </span>
   <span class="font12">individuals </span>
   <span class="font12">proviral </span>
   <span class="font12">research </span>
   <span class="font12">showed </span>
   <span class="font12">study </span>
   <span class="font11">Nat </span>
   <span class="font11">analysis </span>
   <span class="font11">antibody </span>
   <span class="font11">key </span>
   <span class="font11">new </span>
   <span class="font11">rebound </span>
   <span class="font11">receptor </span>
   <span class="font11">rhesus </span>
   <span class="font11">single </span>
   <span class="font11">tissue </span>
   <span class="font11">understanding </span>
   <span class="font11">(University </span>
   <span class="font11">TLR </span>
   <span class="font11">approaches </span>
   <span class="font11">biomarkers </span>
   <span class="font11">blood </span>
   <span class="font11">efficacy </span>
   <span class="font11">functional </span>
   <span class="font11">integration </span>
   <span class="font11">sequences </span>
   <span class="font11">specific </span>
   <span class="font11">subset </span>
   <span class="font11">Nature; </span>
   <span class="font11">[], </span>
   <span class="font11">administration </span>
   <span class="font11">antiviral </span>
   <span class="font11">bNAbs </span>
   <span class="font11">challenges </span>
   <span class="font11">control </span>
   <span class="font11">disease </span>
   <span class="font11">editing </span>
   <span class="font11">engineered </span>
   <span class="font11">latent </span>
   <span class="font11">levels </span>
   <span class="font11">multiple </span>
   <span class="font11">patients </span>
   <span class="font11">proteins </span>
   <span class="font11">provirus </span>
   <span class="font11">remains </span>
   <span class="font11">reservoirs </span>
   <span class="font11">sustained </span>
   <span class="font11">therapy. </span>
   <span class="font11">Clin </span>
   <span class="font11">DNA. </span>
   <span class="font11">Forum </span>
   <span class="font11">However, </span>
   <span class="font11">RNA </span>
   <span class="font11">available </span>
   <span class="font11">cellular </span>
   <span class="font11">clonal </span>
   <span class="font11">clones </span>
   <span class="font11">combination </span>
   <span class="font11">critical </span>
   <span class="font11">currently </span>
   <span class="font11">distribution </span>
   <span class="font11">eliminate </span>
   <span class="font11">enhance </span>
   <span class="font11">expansion </span>
   <span class="font11">host </span>
   <span class="font11">important </span>
   <span class="font11">infections </span>
   <span class="font11">liver </span>
   <span class="font11">means </span>
   <span class="font11">participants </span>
   <span class="font11">presence </span>
   <span class="font11">provide </span>
   <span class="font11">px; </span>
   <span class="font11">response </span>
   <span class="font11">sequencing </span>
   <span class="font11">shown </span>
   <span class="font11">significant </span>
   <span class="font11">strategies </span>
   <span class="font11">strategy </span>
   <span class="font11">target </span>
   <span class="font11">transcription </span>
   <span class="font11">viruses </span>
   <span class="font11">{font-family </span>
   <span class="font11">Maini </span>
   <span class="font11">Mol </span>
   <span class="font11">achieved </span>
   <span class="font11">activation </span>
   <span class="font11">adaptive </span>
   <span class="font11">cells, </span>
   <span class="font11">community </span>
   <span class="font11">cure, </span>
   <span class="font11">defective </span>
   <span class="font11">deleted </span>
   <span class="font11">demonstrated </span>
   <span class="font11">development </span>
   <span class="font11">discussed </span>
   <span class="font11">drug </span>
   <span class="font11">effector </span>
   <span class="font11">evidence </span>
   <span class="font11">font-size </span>
   <span class="font11">high </span>
   <span class="font11">including </span>
   <span class="font11">inhibitors </span>
   <span class="font11">macaques </span>
   <span class="font11">protein </span>
   <span class="font11">reported </span>
   <span class="font11">results </span>
   <span class="font11">targets </span>
   <span class="font11">used </span>
   <span class="font11">vaccination </span>
   <span class="font11">work </span>
   <span class="font11">..â€‚ </span>
   <span class="font11">Box </span>
   <span class="font11">CCR </span>
   <span class="font11">CHB </span>
   <span class="font11">Engl </span>
   <span class="font11">Gene </span>
   <span class="font11">ImmTAV </span>
   <span class="font11">Research </span>
   <span class="font11">Sci </span>
   <span class="font11">acute </span>
   <span class="font11">aimed </span>
   <span class="font11">antiretroviral </span>
   <span class="font11">assays </span>
   <span class="font11">co-infected </span>
   <span class="font11">current </span>
   <span class="font11">double; </span>
   <span class="font11">early </span>
   <span class="font11">effects </span>
   <span class="font11">elimination </span>
   <span class="font11">established </span>
   <span class="font11">features </span>
   <span class="font11">field </span>
   <span class="font11">human </span>
   <span class="font11">low </span>
   <span class="font11">markers </span>
   <span class="font11">model </span>
   <span class="font11">molecules </span>
   <span class="font11">overview </span>
   <span class="font11">people </span>
   <span class="font11">positive </span>
   <span class="font11">production </span>
   <span class="font11">provides </span>
   <span class="font11">replication-competent </span>
   <span class="font11">require </span>
   <span class="font11">responses. </span>
   <span class="font11">result </span>
   <span class="font11">sites </span>
   <span class="font11">small </span>
   <span class="font11">suggested </span>
   <span class="font11">surface </span>
   <span class="font11">terms </span>
   <span class="font11">therapies </span>
   <span class="font11">time </span>
   <span class="font11">treated </span>
   <span class="font11">treatment. </span>
   <span class="font11">trial </span>
   <span class="font11">trials </span>
   <span class="font11">undetectable </span>
   <span class="font11">vaccine </span>
   <span class="font11">various </span>
   <span class="font11">viremia </span>
   <span class="font11">vivo </span>
   <span class="font10">AIDS </span>
   <span class="font10">CRISPR/Cas </span>
   <span class="font10">HBV-specific </span>
   <span class="font10">IL- </span>
   <span class="font10">Invest; </span>
   <span class="font10">Pathog; </span>
   <span class="font10">Ther; </span>
   <span class="font10">VRC </span>
   <span class="font10">absence </span>
   <span class="font10">achieve </span>
   <span class="font10">achieving </span>
   <span class="font10">addressing </span>
   <span class="font10">advancing </span>
   <span class="font10">biomarker </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">capsid </span>
   <span class="font10">cccDNA. </span>
   <span class="font10">characterise </span>
   <span class="font10">circulating </span>
   <span class="font10">compounds </span>
   <span class="font10">decay </span>
   <span class="font10">define </span>
   <span class="font10">differentiated </span>
   <span class="font10">direct </span>
   <span class="font10">effect </span>
   <span class="font10">eradication </span>
   <span class="font10">evaluation </span>
   <span class="font10">followed </span>
   <span class="font10">function </span>
   <span class="font10">highly </span>
   <span class="font10">however, </span>
   <span class="font10">induce </span>
   <span class="font10">innate </span>
   <span class="font10">interruption </span>
   <span class="font10">large </span>
   <span class="font10">likely </span>
   <span class="font10">limited </span>
   <span class="font10">load </span>
   <span class="font10">lower </span>
   <span class="font10">measure </span>
   <span class="font10">mechanisms </span>
   <span class="font10">models </span>
   <span class="font10">potent </span>
   <span class="font10">preclinical </span>
   <span class="font10">prevent </span>
   <span class="font10">progress </span>
   <span class="font10">quantitative </span>
   <span class="font10">reliable </span>
   <span class="font10">required </span>
   <span class="font10">safety </span>
   <span class="font10">selection </span>
   <span class="font10">solid; </span>
   <span class="font10">suppression </span>
   <span class="font10">technology </span>
   <span class="font10">tested </span>
   <span class="font10">type </span>
   <span class="font10">vaccines </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(Box </span>
   <span class="font10">ARV </span>
   <span class="font10">ARVs </span>
   <span class="font10">Acad </span>
   <span class="font10">Africa </span>
   <span class="font10">CD. </span>
   <span class="font10">Cure </span>
   <span class="font10">Data </span>
   <span class="font10">Despite </span>
   <span class="font10">HBcAg </span>
   <span class="font10">HIV/HBV </span>
   <span class="font10">Hepatol; </span>
   <span class="font10">IAS </span>
   <span class="font10">ISs </span>
   <span class="font10">Immunol; </span>
   <span class="font10">Natl </span>
   <span class="font10">PCR </span>
   <span class="font10">Proc </span>
   <span class="font10">Rev </span>
   <span class="font10">SHIV-infected </span>
   <span class="font10">SIV </span>
   <span class="font10">SIV-infected </span>
   <span class="font10">Studies </span>
   <span class="font10">T-cell </span>
   <span class="font10">University, </span>
   <span class="font10">[,]. </span>
   <span class="font10">administered </span>
   <span class="font10">agonist </span>
   <span class="font10">al.A </span>
   <span class="font10">allow </span>
   <span class="font10">and, </span>
   <span class="font10">animals </span>
   <span class="font10">antibodies. </span>
   <span class="font10">assay </span>
   <span class="font10">assess </span>
   <span class="font10">bNAb </span>
   <span class="font10">barriers </span>
   <span class="font10">based </span>
   <span class="font10">body </span>
   <span class="font10">bold </span>
   <span class="font10">broadly </span>
   <span class="font10">cancer </span>
   <span class="font10">cells: </span>
   <span class="font10">chronically </span>
   <span class="font10">clearance </span>
   <span class="font10">clonally </span>
   <span class="font10">contribution </span>
   <span class="font10">courier; </span>
   <span class="font10">cultured </span>
   <span class="font10">cytokines </span>
   <span class="font10">degradation </span>
   <span class="font10">delivered </span>
   <span class="font10">delivery </span>
   <span class="font10">described </span>
   <span class="font10">developed </span>
   <span class="font10">did </span>
   <span class="font10">differences </span>
   <span class="font10">disabling </span>
   <span class="font10">doses </span>
   <span class="font10">effective </span>
   <span class="font10">em; </span>
   <span class="font10">facing </span>
   <span class="font10">fingolimod </span>
   <span class="font10">focus </span>
   <span class="font10">formation </span>
   <span class="font10">frequency </span>
   <span class="font10">genome </span>
   <span class="font10">half-life </span>
   <span class="font10">hepatocyte </span>
   <span class="font10">humoral </span>
   <span class="font10">immunotherapy </span>
   <span class="font10">improve </span>
   <span class="font10">increased </span>
   <span class="font10">individuals. </span>
   <span class="font10">information </span>
   <span class="font10">interventions </span>
   <span class="font10">involving </span>
   <span class="font10">limitations </span>
   <span class="font10">long </span>
   <span class="font10">long-term </span>
   <span class="font10">lymph </span>
   <span class="font10">major </span>
   <span class="font10">molecular </span>
   <span class="font10">monkeys. </span>
   <span class="font10">monoclonal </span>
   <span class="font10">needed </span>
   <span class="font10">neutralizing </span>
   <span class="font10">order </span>
   <span class="font10">phase </span>
   <span class="font10">plasma </span>
   <span class="font10">populations </span>
   <span class="font10">potentially </span>
   <span class="font10">prior </span>
   <span class="font10">produce </span>
   <span class="font10">provided </span>
   <span class="font10">pt;} </span>
   <span class="font10">recent </span>
   <span class="font10">reduced </span>
   <span class="font10">regulatory </span>
   <span class="font10">replication. </span>
   <span class="font10">research. </span>
   <span class="font10">reservoir. </span>
   <span class="font10">reverse </span>
   <span class="font10">sensitivity </span>
   <span class="font10">showing </span>
   <span class="font10">site </span>
   <span class="font10">splicing </span>
   <span class="font10">status </span>
   <span class="font10">studies, </span>
   <span class="font10">suppression. </span>
   <span class="font10">suppressive </span>
   <span class="font10">taking </span>
   <span class="font10">throughput </span>
   <span class="font10">useful </span>
   <span class="font10">vectors </span>
   <span class="font10">virological </span>
   <span class="font10">virus. </span>
   <span class="font10">vitro </span>
  </p>
 </body>
</html>
